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Abstract
Introduction: Extra-hepatic biliary atresia (EHBA) is an important cause of neonatal cholestasis.
Several infectious agents have been proposed as etiologic factors such as Rotavirus and Reovirus.
There is limited data on the role of Epstein Barr virus (EBV) infection in EHBA, so we decided to
study the presence of EBV virus in a series of 16 proven EHBA cases by Chromogenic in situ
hybridization (CISH) technique.
Methods: In the current study a total of 16 liver wedge biopsies of proven cases of EHBA were
selected in a period of 4 years. CISH staining for EBV-encoded RNA (EBER) transcript was
performed.
Results: The review of H&E-stained slides of liver biopsies revealed fibrosis and marked ductular
proliferation. In CISH-stained slides, EBV trace was observed in hepatocytes in two cases and in
biliary epithelium in one case of EHBA.
Discussion: Considering the association of hepatitis with the Epstein-Barr virus in later life, it is
likely that EBV hepatitis and its complications occur in the neonatal/perinatal period. Since EHBA
is a relatively rare disease, a similar study on wedge biopsies of this number of proven cases of
EHBA has not been performed to date. Current observation proposes the need for a study of
larger series and employing other methods for confirming the etiologic role of EBV in EHBA cases.
Introduction
Extrahepatic biliary atresia can be defined as a progressive
necroinflammatory process involving a segment or the
entire extrahepatic biliary tree leading to loss of patency of
Published: 28 April 2008
Diagnostic Pathology 2008, 3:19 doi:10.1186/1746-1596-3-19
Received: 7 February 2008
Accepted: 28 April 2008
This article is available from: http://www.diagnosticpathology.org/content/3/1/19
© 2008 Mahjoub et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Diagnostic Pathology 2008, 3:19 http://www.diagnosticpathology.org/content/3/1/19
Page 2 of 4
(page number not for citation purposes)
the lumen and obstruction to bile flow [1]. EHBA occurs
in 8 in 15000 live births resulting in 250 to 400 new cases
per year in the USA [1]. Although we don't have a docu-
mented incidence rate of the disease in Iran, we encounter
these cases frequently, especially in summer and winter.
The pathogenesis of EHBA remains a mystery, though
most of the causal theories and research to date can be
grouped into four main categories: infectious or toxin
exposure, abnormal morphogenesis, genetic predisposi-
tion and immune dysregulation [1]. Reovirus and Rotavi-
rus particles have been found in liver and bile duct
remnants of patients with EHBA [2,3]. Evidence for
human papilloma virus (HPV) types 6 and 18 has also
been reported [4]. There is no evidence for a causative role
by hepatitis B or C in the disease [5]. The available data
about EBV is rather limited, but there is a serologically
documented case on record [6]. However, EBV-associated
hepatitis is well recognized [7].
EBV is a member of the herpesvirus family. As with other
herpesviruses, EBV is an enveloped virus that contains a
DNA core surrounded by an icosahedral nucleocapsid and
infection is endemic around the world [8]. It is now
known that EBV infects 90% of the world's adult popula-
tion. Upon infection, the individual remains a lifelong
carrier of the virus [8]. Available detection methods for
EBV are: PCR, in situ hybridization (ISH) and immuno-
histochemistry (IHC). ISH is the standard procedure for
detecting EBV-encoded RNAs (EBERs) [9]. According to
some authors, PCR and chromogenic in situ hybridization
(CISH) are equally sensitive in detecting EBV in routinely
processed liver biopsies, while IHC is an insensitive
method [9]. Although larger biopsies are generally needed
for CISH, in contrast to PCR, it allows identification and
distinction of infected cell types [9]. This is generally con-
sidered an advantage, since the correct diagnosis of EBV
hepatitis requires detection of the EBERs in parenchymal
cells, not periportal lymphocytes [10]. The ready imple-
mentation of ISH in pathology laboratories makes it a
useful ancillary tool in confirming the diagnosis of EBV
infection in equivocal cases. This technique is based on
detection of EBV-encoded RNAs (EBERs). EBER 1 and 2
are nonpolyadenylated, uncapped, noncoding RNAs of
167 and 172 nucleotides respectively, and are expressed
abundantly in nearly all EBV-infected cells [11]. Peptide
nucleic acid (PNA) probes are usually employed for
hybridization. PNA molecules are DNA mimics, where
the negatively charged sugar-phosphate backbone of DNA
is replaced by a neutral polyamide backbone formed by
repetitive units of N-(2-aminoethyl) glycine [12]. Individ-
ual nucleotide bases are attached to each of the units to
provide a molecular design that enables PNA to hybridize
to complementary nucleic acid targets according to the
Watson and Crick base-pairing rules. The synthetic back-
bone provides PNA probes with unique hybridization
characteristics, such as more rapid and stronger binding to
complementary targets [13].
EBV infection is seen in Iran rather commonly and we sug-
gest a role for it at least in a fraction of EHBA cases. There
is limited data in EHBA on the role of EBV infection, so we
decided to study the presence of EBV virus in a series of 16
proven EHBA cases by CISH technique.
Materials and methods
A total of 17 liver wedge biopsies were selected in a period
of 4 years from 2004 to 2008 in Markaze Tebbi Koodakan.
All patients had confirmation of extrahepatic biliary
artesia by intraoperative cholangiogaphy and underwent
Kasai operation subsequently. Liver wedge biopsies were
taken just before the Kasai operation. Patients records
were studied for clinical and biochemical data. H&E-
stained slides and formalin-fixed paraffin-embedded
blocks were available for study. CISH staining for EBV
encoded RNA (EBER) transcripts were performed on
standard 5-μm deparaffinized tissue sections mounted on
silanized slides. Slides were digested with proteinase K for
30 minutes, incubated with Fluorescein isothiocyanate
(FITC)-conjugated EBER PNA-probes (DAKO code-Nr.Y
5200), followed by incubation with anti-FITC alkaline
phosphatase-conjugated antibody and 4-nitroblue tetra-
zolium chloride/5-bromo-4-chloro-3-indolyl phosphate
substrate combined with levamisole (DAKO code-Nr. K
5201). Manufacturer's instructions were followed care-
fully, and contamination with RNAses was avoided
strictly. Glassware was made RNAse-free by an overnight
incubation at 200°C, and Diethyl Pyrocarbonate (DPEC)-
treated water was used for preparation of reagents. Cells
exhibiting nuclear staining were considered positive. Pos-
itive and negative controls were included in each run as
recommended by the manufacturer.
Results
Of 17 selected patients, one has limited tissue and was
excluded from study. Of 16 remaining patients, ten (59%)
were male, and the rest (41%) were female. Age of
patients at time of admission ranged from 36 to 152 days
with mean and standard deviation of 72 and 39 days
respectively. Seasonal distribution of the patients had two
peaks, one in summer and another in winter. Total
bilirubin ranged from 4.4 to 12.7 mg/dL with mean and
standard deviation of 9.53 and 2.75 mg/dL, respectively.
Alkaline Phosphatase ranged from 919 to 2703 IU/dL
with mean and standard deviation of 1585 and 469 IU/
dL, respectively. Aspartate aminotransferase (AST) ranged
from 92 to 507 IU/dl with mean and standard deviation
of 296 and 144 respectively. Alanine Aminotransferase
(ALT) ranged from 40 to 475 IU/dl with mean and stand-
ard deviation of 158 and 108, respectively (Table 1). The
review of H&E-stained slides of liver biopsies revealedDiagnostic Pathology 2008, 3:19 http://www.diagnosticpathology.org/content/3/1/19
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fibrosis and marked ductular proliferation in all but one
case which showed minimal ductular proliferation.
Reviewing the CISH slides showed EBER-positive hepato-
cytes in two patients (Figure 1), and in biliary epithelium
in one case (Figure 2). Another slide revealed periportal
lymphocytes positive for EBER. Confirmation by serology
studies was not performed.
Discussion
EHBA is an important cause of neonatal cholestasis. Sev-
eral infectious agents have been proposed such as Rotavi-
rus and Reovirus [2,3]. The available data about EBV is
rather limited, but there is a serologically documented
case on record [6]. Although EBV hepatitis has been
reported in some articles [7], there is no published article
about EBV in liver biopsies in EHBA. The correct diagnosis
of EBV hepatitis requires detection of the EBERs in paren-
chymal cells, not periportal lymphocytes, since some B
cells in the circulation are infected with EBV [10]. How-
ever, EBER-positive cells can be sparse and easily over-
looked [10], therefore only wedge biopsies were included
in the study. Considering the association of hepatitis with
the Epstein-Barr virus in later life, it is likely that EBV hep-
atitis and its complications occur in the neonatal/perina-
tal period. Also, cholestatic jaundice has been well-
documented in patients with EBV hepatitis [14,15]. Even
though the underlying mechanisms for EBV-induced
cholestasis are not known, one possibility is that EBV may
serve as the trigger for an autoimmune reaction in these
cases. This is a phenomenon that has been described in
genetically predisposed individuals [16].
A high number of EBV-positive cases were not expected
from the very beginning of the study; meanwhile only 17
wedge biopsies were available in our referral center in the
specified period of time. A case-series was designed,
instead of a case-control study, simply because much
more cases are needed to prove or rule out the causative
role of EBV in EHBA using case-control method. On the
other hand, EBV trace was found in three cases, two in
Detection of EBV by CISH Figure 2
Detection of EBV by CISH. EBER-positive cholangiocytes 
(dark nuclei) were detected in this case (arrow), (original 
magnification × 400).
Table 1: Gender and Age of admission and other paraclinical 
data.
ID Gender Age(days) ALP AST ALT
1 F 70 1705 184 83
2 M 36 972 426 475
3 F 113 1514 374 116
4 M 52 1421 N/A N/A
5 M 152 1451 486 209
6 F 114 N/A 420 204
7 M 37 2703 507 157
8 F 85 919 92 112
9 F 28 1697 227 70
10 M 74 N/A N/A N/A
11 M 72 N/A 207 197
12 F 72 N/A N/A N/A
13 M 90 1246 276 128
14 M 39 1657 175 129
15 M 28 1898 92 40
16 F 84 1831 385 134
ALP: Alkaline phosphatase, AST: Aspartate aminotransferase, ALT: 
Alanine aminotransferase.
Detection of EBV by CISH Figure 1
Detection of EBV by CISH. EBER-positive hepatocytes (dark 
nuclei) were detected in this case (arrow), (original magnifi-
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hepatocytes and one in biliary epithelium, a feature that
has not been described previously and still is worthy of
recording. This proposes the need for a study of a larger
series and employing other methods for confirming or
ruling out the etiologic role of EBV in EHBA cases.
Drawbacks of the current study other than a limited
number of cases include unavailability of serologic data
and PCR for EBV infection. However according to N. Suh
et al. PCR and ISH are equally sensitive in detecting EBV
in routinely processed liver biopsies [10]. Since EHBA is
relatively rare disease, a similar study on wedge biopsies
of this number of proven cases of EHBA has not been per-
formed to date.
Conclusion
CISH staining was performed on liver wedge biopsies of
16 proven cases of EHBA, which represents the largest
series for a biopsy-based study on EBV infection in this
disorder. Hepatocytes were found to be positive in two
cases and one case revealed positivity in biliary epithe-
lium. This observation proposes the need for a study of a
larger series and employing other methods for confirming
the etiologic role of EBV in EHBA cases. Whether the EBV
infection is responsible for the development of some cases
of EHBA or not, remains to be proved in future studies
performed on larger series.
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